300869 康泰医学
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.519-3.9938.34410.46920.795
总资产报酬率 ROA (%)0.341-2.6244.7746.01714.420
投入资产回报率 ROIC (%)0.347-2.6824.9306.26515.493

边际利润分析
销售毛利率 (%)54.72949.35057.58247.47749.076
营业利润率 (%)2.930-14.07925.00130.79244.651
息税前利润/营业总收入 (%)2.286-19.21720.78923.74831.235
净利润/营业总收入 (%)2.733-16.23622.19427.55238.775

收益指标分析
经营活动净收益/利润总额(%)86.413-16.42195.64173.11897.763
价值变动净收益/利润总额(%)98.536-32.6277.24924.8840.388
营业外收支净额/利润总额(%)0.3288.577-0.3270.0540.551

偿债能力分析
流动比率 (X)8.62714.2545.3972.3001.415
速动比率 (X)7.65512.2334.3901.9130.977
资产负债率 (%)36.71831.85136.33848.34134.743
带息债务/全部投入资本 (%)35.24030.23434.34045.63331.354
股东权益/带息债务 (%)182.840229.547190.122117.616217.347
股东权益/负债合计 (%)172.345213.963175.196106.864187.830
利息保障倍数 (X)-3.5025.033-5.032-3.363-2.286

营运能力分析
应收账款周转天数 (天)36.66532.21148.34857.36833.253
存货周转天数 (天)468.207544.801507.615408.550273.495